Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated February 12, 2015, covers events occurring on February 11, 2015. The primary event is the completion of the acquisition of CRC Health Group, Inc. ("CRC"), a leading provider of addiction and behavioral disorder treatment services operating 116 facilities across 30 states. The filing details the financing arrangements, definitive agreements, and governance changes associated with this transaction.
Key Financial Metrics and Capital Structure
The filing outlines significant changes to the Company's capital structure to fund the CRC acquisition. Specific financial metrics for revenue, profit, or cash flow are not provided in this text, as they are incorporated by reference from prior filings. Key debt and liquidity metrics include:
- Senior Notes Issuance: Sold $375 million aggregate principal amount of 5.625% Senior Notes due 2023.
- Term Loan B Facility: Activated a new $500 million incremental Term Loan B facility.
- Revolving Credit Facility: Borrowed $25 million under the existing revolving credit facility.
- Cash Usage: Utilized approximately $70 million of cash on hand.
- Equity Issuance: Issued 5,975,326 shares of common stock to CRC shareholders.
- Interest Rates: Term Loan B bears interest at the Applicable Rate (3.50% for Eurodollar, 2.50% for Base Rate) plus the applicable benchmark rate.
Material Changes Versus Prior Period
The most significant material change is the consolidation of CRC into Acadia, substantially expanding the Company's operational footprint. Additionally, the Company's debt load has increased significantly through the issuance of new notes and term loans. The filing details specific adjustments to financial covenants to accommodate the acquisition:
- Consolidated Leverage Ratio: Maximum covenant levels were increased for fiscal quarters in 2014 through 2018, peaking at 6.75x for the first two quarters of 2015.
- Senior Secured Leverage Ratio: Increased to 3.75x for the period ending September 30, 2015, and 3.50x thereafter.
- Credit Agreement Amendments: Added Citibank, N.A. as an L/C Issuer and increased Letter of Credit and Swing Line sublimits to $20 million each.
Guidance, Outlook, Risks, and Unusual Items
The filing does not contain forward-looking revenue guidance or management commentary on future performance. However, it outlines several risks and contractual obligations:
- Covenant Restrictions: The Indenture for the Senior Notes limits the Company's ability to pay dividends, incur additional debt, sell assets, or merge without meeting specific conditions. Certain covenants may be suspended if the Notes achieve an investment-grade rating.
- Registration Rights Penalty: If the Company fails to file required registration statements within specified timelines (360/450 days), the interest rate on the Notes will increase by 0.25% per annum, up to a maximum of 1.0% additional interest.
- Governance Changes: An Amended and Restated Stockholders Agreement grants Waud Capital Partners (WCP) the right to designate one additional board nominee and includes a standstill provision preventing Bain Capital from acquiring additional shares or mounting a proxy contest.
- Director Appointment: Christopher R. Gordon of Bain Capital was appointed as a Class III director.
Investor Verification Checklist
- Verify the pro forma financial impact of the CRC acquisition by reviewing the Unaudited Pro Forma Condensed Combined Financial Information filed as Exhibit 99.1 on January 28, 2015.
- Review the Audited and Unaudited Consolidated Financial Statements of CRC (Exhibits 99.2 and 99.3) to assess the target's historical performance.
- Confirm the specific terms of the Indenture (Exhibit 4.1) regarding redemption premiums and covenant suspension triggers.
- Monitor the Company's ability to meet the new, higher leverage ratio covenants in the coming fiscal quarters.
- Track the timeline for the registration statement filing to avoid the 0.25% interest rate penalty on the Senior Notes.